We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002049:SZSEUnigroup Guoxin Microelectronics Co., Ltd. Analysis

Data as of 2026-03-07 - not real-time

CN¥75.16

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading well below its recent moving averages, indicating short‑term weakness. Technical momentum is bearish as the MACD line sits beneath its signal and the RSI is in the lower half of its range. Volume has been slipping, which adds pressure to the downside. Fundamental margins remain robust, with gross and operating profitability well above many peers. Cash generation is strong and the balance sheet shows ample liquidity relative to debt. The dividend payout is modest, leaving room for continued earnings retention.
Valuation metrics suggest the market price is significantly higher than intrinsic estimates, pointing to an overvalued condition. The price‑to‑earnings multiple outpaces the sector average, while the price‑to‑book ratio is elevated. Nonetheless, revenue growth remains double‑digit and the company is well positioned in emerging AI and automotive semiconductor markets. The strategic product mix across power devices and security chips offers diversification benefits. With a low beta and limited currency exposure, systematic market risk is muted. Overall, the stock may be attractive for long‑term investors who can tolerate the current premium.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • bearish MACD divergence
  • declining volume trend
  • price near support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong cash position
  • sustained revenue growth
  • elevated valuation moderates upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • strategic exposure to AI and automotive chips
  • high operating margins
  • dividend sustainability supports total return

Key Metrics & Analysis

Financial Health

Revenue Growth33.60%
Profit Margin23.28%
P/E Ratio44.2
ROE11.23%
ROA4.78%
Debt/Equity11.72
P/B Ratio4.7
Op. Cash FlowCN¥779.7M
Free Cash FlowCN¥13.0M
Industry P/E36.2

Technical Analysis

TrendNeutral
RSI39.6
SupportCN¥73.99
ResistanceCN¥85.38
MA 20CN¥78.22
MA 50CN¥79.81
MA 200CN¥75.25
MACDBearish
VolumeDecreasing
Fear & Greed Index68.77

Valuation

Fair ValueCN¥3.09
Target PriceCN¥100.63
Upside/Downside33.89%
GradeOvervalued
TypeGrowth
Dividend Yield0.28%

Risk Assessment

Beta-0.06
Volatility40.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.